A breakdown in insulin signaling under metabolic stress can lead to persistent systemic hyperinsulinemia and insulin resistance, which is characterized as a reduction in the impact of insulin on important target tissues (including adipose tissue, liver, and skeletal muscle). The gene discussed is INS; the disease is Insulin resistance.